CRWV
UBS is betting against the room
UBS just started coverage on CoreWeave with a Buy rating, and it’s doing it with a bit of swagger: the bank called it a non-consensus idea and sees roughly 40% upside from here. In other words, UBS is basically saying, “Everyone else may be squinting at the same stock, but we see a different movie.”
Why investors should care
For CoreWeave, this is less about a random analyst note and more about a fresh narrative checkup. The stock has already been a magnet for attention thanks to its AI infrastructure growth, but it’s also been battling the usual suspects: big spending, dilution fears, and the market’s general suspicion that AI winners can turn into capital-hungry beasts fast.
What matters here:
- UBS is putting a bullish stamp on the story
- The call suggests CoreWeave still has meaningful room to run
- The market will now have to decide whether this is smart contrarianism or just Wall Street getting a little too excited
The bigger picture
Analyst calls don’t move the business, but they can absolutely move sentiment — especially on a name as high-beta as CoreWeave. If you’ve been wondering whether the AI infrastructure trade still has legs, UBS just tossed another log on the fire.
Big picture: the company is still one of the market’s favorite “show me” stories, and UBS just moved it a little closer to “show me the money.”